MRK

Merck & Co., Inc.

Health Care · Pharmaceuticals

$218.30 sample

-0.86 (-0.39%) 1D

Market cap

$1.14T

Price as of

2026-10-15

Latest filing

8-K · 2026-10-12

Alerts

8

Price$218.30 +12.53% 3M daily closessample

221.50193.80

2026-07-202026-08-112026-09-022026-09-232026-10-15

purchase / approvalsale / rejectionfiling / neutral

Latest events

Filings, trades, FDA; newest first

Oct 12SECDEF 14A filed
Oct 02INSInsider buy: Chief Financial Officer
Sep 29SEC10-Q filed
Sep 18INSInsider sell: Director
Sep 15INSInsider sell: 10% owner
Sep 09INSInsider sell: 10% owner
Sep 02INSInsider sell: Chief Executive Officer
Aug 27INSInsider buy: 10% owner

Sign up to see the real MRK record →

Company facts

SEC EDGAR registration

Name: Merck & Co., Inc.
Sector: Health Care
Industry: Pharmaceuticals
Smart-money score: +7sample, -100 to +100
Reporting currency: USD

Who is positioning in MRK

sample

Insiders: 33 insider transactions over 90 days, net selling, $869.5M
Congress: 2 members traded over 90 days
Institutions · 13F: 26 funds hold $11.0B
Activists · 13D/G: No 13D/13G activist filings on record

How are the fundamentals trending?

sample, by period end

Revenue$33.2B +17.1% y/y

Q4 2024Q3 2026

Inventory$20.4B +19.0% y/y

Q4 2024Q3 2026

Accounts receivable$15.7B +16.4% y/y

Q4 2024Q3 2026

Total debt$39.4B +4.7% y/y

Q4 2024Q3 2026

Peers

sample

Sample peer A: $199.6B +12.7% 3M
Sample peer B: $1.04T +3.1% 3M
Sample peer C: $979.9B +11.8% 3M
Sample peer D: $960.9B +5.0% 3M
Sample peer E: $296.5B +10.5% 3M